ImmunoPrecise Antibodies Ltd - IPA Company Short-Term Debt

Public company logo of immunoprecise.com (IPA)

The foundation of the ImmunoPrecise Antibodies (IPA) business is a network of high-tech vivariums and laboratories across North America and Europe operating under strict safety regulations. The CRO services model allows for the efficient allocation of capital expenditures on equipment, thereby stabilizing the operating margin. The share price history reflects the dynamics of a company whose LENS AI system accelerates drug development for pharma behemoths, while the separate_debt_short metric stands at 0.00.

IPA (ImmunoPrecise Antibodies) Company Short-Term Debts history from 07/04/2022 to 09/04/2025

ImmunoPrecise Antibodies Ltd - analytical breakdowns and key metrics (IPA)

- price and consensus price forecast:
Price Chart ImmunoPrecise|IPA - Consensus Target
- market capitalization data:
Market Value ImmunoPrecise Antibodies Ltd.|IPA - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value per Share ImmunoPrecise Antibodies|IPA - Book Capitalization|Market Value to Book Value Ratio immunoprecise.com|IPA - Total Business Assets
- debt and liquidity data:
Debt to Equity ImmunoPrecise Antibodies|IPA - Long-Term Liabilities to Capital|Short-Term Debt to Equity ImmunoPrecise|IPA - Company Aggregate Indebtedness|Debt to Book Capitalization Ratio ImmunoPrecise Antibodies Ltd.|IPA - Company Long-Term Loans and Borrowings|Company Short-Term Debts ImmunoPrecise Antibodies
Fundamental company valuation:IPA immunoprecise.com
Finished products of ImmunoPrecise

The development of the AI-driven DNA analysis platform at ImmunoPrecise Antibodies (IPA) requires significant investments in IT infrastructure, making liquidity control critically important. The total amount of liabilities maturing within one year quantifies the operational debt load, allowing the company to assess the risk of cash flow gaps and the efficiency of working capital management through short-term borrowings amid its dependence on pharmaceutical contracts.

Competitors of ImmunoPrecise Antibodies (IPA)

TEM: Company Short-Term Debt|QGEN: Company Current Liabilities|IONS (Ionis Pharma) - Company Short-Term Debt|Company Current Liabilities Repligen Inc.|RNA (Avidity Biosciences) - Company Current Liabilities|Company Short-Term Debts CRSP|Company Short-Term Debt GeneDx WGS|Company Short-Term Indebtedness RARE (Ultragenyx Pharmaceutical Inc.)|BEAM: Company Short-Term Debt|Sarepta Corp - Short-Term Debt|Company Short-Term Debt Twist Bioscience|TXG: Current Liabilities|Company Short-Term Debt Intellia Therapeutics, Inc. NTLA|Stoke Therapeutics Inc (STOK) - Company Short-Term Loans and Borrowings|Company Short-Term Debts BLFS (BioLife Corp)|Short-Term Debt Wave Pharma|Company Short-Term Debts MAZE (Maze Therapeutics Inc)|Company Current Liabilities sionnatx.com (SION)|Company Short-Term Debts PRME|Taysha Gene Therapies Inc - Short-Term Debt Volume|Company Short-Term Debt QURE (uniQure Corp)|MGTX - Short-Term Debt Volume|Company Short-Term Debts RGNX|Short-Term Debt solidbio.com|OCGN - Company Current Liabilities|Company Short-Term Loans and Borrowings Pacific Biosciences of California, Inc.|Company Short-Term Debts BNTC|Company Short-Term Debts DSGN (Design Corp)|RCKT - Company Short-Term Debt|FDMT - Company Short-Term Indebtedness|Company Current Liabilities Lexeo LXEO|KRRO - Amount of Current Liabilities|Editas - Company Short-Term Debts|Silence Therapeutics Corp (SLN) - Short-Term Debt Volume|Company Short-Term Debts ProQR|Company Short-Term Debt CDXS|Sangamo Therapeutics, Inc. - Company Short-Term Debt|Short-Term Debt nautilus.bio (NAUT)|MGX - Company Short-Term Debts|Company Short-Term Indebtedness precisionbiosciences.com DTIL|Company Short-Term Debts GBIO (Generation Bio Corp)|BOLD - Short-Term Debt Volume|Company Short-Term Debts XCUR|IMNN (Imunon) - Short-Term Debt|PHIO: Company Short-Term Debt|Short-Term Debt Volume Mustang Bio Corp|RNAZ (TransCode Therapeutics) - Company Short-Term Debts|Short-Term Debt Volume BNGO (bionanogenomics.com)|Applied DNA Sciences, Inc. (APDN) - Company Short-Term Debt|Current Liabilities bluebird bio Inc. BLUE|Omega - Company Short-Term Debts|OMIC - Company Short-Term Debts|Company Short-Term Debts Regulus Therapeutics|SYRS (syros.com) - Company Short-Term Indebtedness|Company Short-Term Debt Telesis Bio (TBIO)|Company Short-Term Indebtedness TRACON Pharmaceuticals Inc.|Company Short-Term Debts UBX